RM-493 Treatment Trial in Proopiomelanocortin (POMC) Deficient Patients

Clinical trial NCT02507492 · UNKNOWN

Trial details

NCT number: NCT02507492
Sponsor: Charite University, Berlin, Germany
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Homozygous or Compound Heterozygous POMC, LEPR or PCSK1 Gene Mutation

Start date: 2015-01-01
Primary completion: 2018-01-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.